GEOVAX LABS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.185 USD | -10.28% |
|
+36.70% | -41.18% |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 0.176 | 12.03 | 23.1 | 16.6 | 9.637 | 8.053 | - |
| Enterprise Value (EV) 1 | 0.176 | 12.03 | 23.1 | 16.6 | 9.637 | 8.053 | 8.053 |
| P/E ratio | -0.02 x | -1.58 x | -1.19 x | -0.76 x | -0.38 x | -0.37 x | -1.81 x |
| Yield | - | - | - | - | - | - | - |
| Capitalization / Revenue | - | 6.6 x | 59.9 x | 204 x | - | - | 0.33 x |
| EV / Revenue | - | 6.6 x | 59.9 x | 204 x | - | - | 0.33 x |
| EV / EBITDA | - | - | - | -12,70,503 x | - | - | - |
| EV / FCF | - | -41,38,119 x | - | -8,65,992 x | - | - | - |
| FCF Yield | - | -0% | - | -0% | - | - | - |
| Price to Book | - | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 0.98 | 237 | 425 | 1,756 | 1,780 | 2,528 | - |
| Reference price 2 | 180.0 | 50.70 | 54.30 | 9.453 | 5.415 | 3.185 | 3.185 |
| Announcement Date | 24/03/20 | 23/03/21 | 09/03/22 | 23/03/23 | 29/02/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 1.824 | 0.3855 | 0.0815 | - | - | 24.3 |
| EBITDA | - | - | - | -13.06 | - | - | - |
| EBIT 1 | - | -2.817 | -18.75 | -14.03 | -26.74 | -31.4 | -25.8 |
| Operating Margin | - | -154.46% | -4,862.73% | -17,206.62% | - | - | -106.17% |
| Earnings before Tax (EBT) 1 | - | -2.958 | -18.57 | -14.02 | -25.97 | -31.4 | -25.8 |
| Net income 1 | -2.371 | -2.958 | -18.57 | -14.02 | -25.97 | -31.4 | -25.8 |
| Net margin | - | -162.21% | -4,817.2% | -17,197.51% | - | - | -106.17% |
| EPS 2 | -11,775 | -32.10 | -45.60 | -12.45 | -14.29 | -8.720 | -1.760 |
| Free Cash Flow | - | -2.907 | - | -19.16 | - | - | - |
| FCF margin | - | -159.42% | - | -23,506.03% | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 24/03/20 | 23/03/21 | 09/03/22 | 23/03/23 | 29/02/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 0.165 | 0.0815 | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBIT 1 | -13.74 | -2.428 | -2.242 | -3.971 | -5.388 | -4.271 | -6.179 | -8.6 | -7.694 | - | -7 | -8.4 | -10.2 |
| Operating Margin | -8,331.56% | -2,978.09% | - | - | - | - | - | - | - | - | - | - | - |
| Earnings before Tax (EBT) 1 | -13.74 | -2.428 | -2.242 | -3.968 | -5.384 | -4.038 | -5.928 | -8.409 | -7.593 | - | -7 | -8.4 | -10.2 |
| Net income 1 | -13.74 | -2.428 | -2.242 | -3.968 | -5.384 | -4.038 | -5.928 | -8.409 | -7.593 | - | -7 | -8.4 | -10.2 |
| Net margin | -8,331.11% | -2,977.46% | - | - | - | - | - | - | - | - | - | - | - |
| EPS 2 | -33.60 | -5.100 | -2.700 | -2.550 | -3.000 | -2.250 | -3.300 | -4.800 | -3.940 | -2.470 | -4.430 | -1.775 | -1.510 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 09/03/22 | 27/04/22 | 03/08/22 | 09/11/22 | 23/03/23 | 04/05/23 | 09/08/23 | 08/11/23 | 29/02/24 | 14/05/24 | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow | - | -2.91 | - | -19.2 | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - | - |
| Capex | - | - | - | 0.13 | - | - | - |
| Capex / Sales | - | - | - | 164.68% | - | - | - |
| Announcement Date | 24/03/20 | 23/03/21 | 09/03/22 | 23/03/23 | 29/02/24 | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
3.185
USD
Average target price
7
USD
Spread / Average Target
+119.78%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -41.18% | 80.53L | |
| +19.41% | 4.55TCr | |
| +38.65% | 3.94TCr | |
| -8.62% | 3.85TCr | |
| +26.95% | 3.07TCr | |
| -13.50% | 2.6TCr | |
| +10.74% | 2.59TCr | |
| +44.87% | 1.41TCr | |
| +34.36% | 1.27TCr | |
| -7.14% | 1.13TCr |
- Stock Market
- Equities
- GOVX Stock
- Financials GeoVax Labs, Inc.
